Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Pascal Demoly

From: Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose

Contact corresponding author